Want to see BDMD full AI Analyst Report?
Top Page
Baird Medical Investment Holdings
(NASDAQ:BDMD)
Select Model
Select Model
Rating:44Neutral
Price Target:
$0.82
▼(-30.93% Downside)
Action:Reiterated
Date:09/22/26
The score is held down primarily by deteriorating financial performance (sharp revenue decline, swing to losses) and persistently negative operating/free cash flow, which raises funding risk. Technicals add further pressure as the stock remains in a strong downtrend with negative MACD and weak momentum. Valuation provides limited offset because negative earnings make P/E less meaningful and there is no dividend yield support.
Positive Factors
2026 Revenue and Profit Recovery
The first-half 2026 rebound indicates that international expansion and licensing activity can restore growth after the prior-year downturn. A return to positive earnings, even at a modest level, improves operating resilience and provides a foundation for rebuilding profitability.
Negative Factors
Persistently Negative Cash Generation
Repeatedly negative operating and free cash flow shows that reported business activity has not yet translated into internally funded operations. If this persists, the company may need external capital to support commercialization, increasing funding dependence and reducing financial flexibility.
Read all positive and negative factors
Positive Factors
Negative Factors
2026 Revenue and Profit Recovery
The first-half 2026 rebound indicates that international expansion and licensing activity can restore growth after the prior-year downturn. A return to positive earnings, even at a modest level, improves operating resilience and provides a foundation for rebuilding profitability.
Read all positive factors
Baird Medical Investment Holdings (BDMD) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$33.35M
Dividend YieldN/A
Average Volume (3M)43.90K
Price to Earnings (P/E)―
Beta (1Y)-0.73
Revenue GrowthN/A
EPS GrowthN/A
CountryUS
Employees146
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)N/A
Shares Outstanding42,208,763
10 Day Avg. Volume57,012
30 Day Avg. Volume43,901
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.21
Price to Sales (P/S)1.68
P/FCF Ratio-27.26
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Baird Medical Investment Holdings Business Overview & Revenue Model
Company Description
Based in China, Baird Medical Investment Holdings Limited and its associated entities specialize in engineering and commercializing microwave ablation medical apparatus. These sophisticated instruments are employed in the minimally invasive manage...
Baird Medical Investment Holdings Financial Statement Overview
Summary
Income Statement
34
Negative
Balance Sheet
56
Neutral
Cash Flow
22
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.49M | 22.54M | 37.04M | 31.46M | 35.09M | 27.72M |
| Gross Profit | 20.97M | 18.88M | 32.65M | 27.23M | 28.04M | 23.18M |
| EBITDA | -13.02M | -24.53M | 16.17M | 12.88M | 16.29M | 14.16M |
| Net Income | -15.97M | -27.28M | 12.45M | 10.55M | 12.57M | 11.68M |
Balance Sheet | ||||||
| Total Assets | 73.85M | 69.70M | 77.96M | 56.71M | 42.62M | 26.12M |
| Cash, Cash Equivalents and Short-Term Investments | 289.08K | 178.32K | 2.97M | 1.63M | 1.91M | 3.44M |
| Total Debt | 14.22M | 19.30M | 20.88M | 9.90M | 7.44M | 2.93M |
| Total Liabilities | 39.22M | 38.48M | 38.20M | 21.00M | 16.84M | 10.26M |
| Stockholders Equity | 34.77M | 31.37M | 39.66M | 35.75M | 25.93M | 5.20M |
Cash Flow | ||||||
| Free Cash Flow | 1.85M | -1.39M | -9.17M | -3.66M | -5.47M | 3.87M |
| Operating Cash Flow | 1.85M | -1.34M | -6.31M | -1.02M | 485.97K | 5.26M |
| Investing Cash Flow | 2.29K | -42.31K | -2.85M | -2.64M | -5.92M | -1.39M |
| Financing Cash Flow | -3.59M | -1.39M | 10.72M | 3.46M | 4.41M | -1.93M |
Baird Medical Investment Holdings Technical Analysis
Negative
1.18
Price Trends
1.09
Negative
1.23
Negative
1.44
Negative
Market Momentum
-0.07
Positive
23.79
Positive
25.62
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BDMD, the sentiment is Negative. The current price of 1.18 is above the 20-day moving average (MA) of 1.06, above the 50-day MA of 1.09, and below the 200-day MA of 1.44, indicating a bearish trend. The MACD of -0.07 indicates Positive momentum. The RSI at 23.79 is Positive, neither overbought nor oversold. The STOCH value of 25.62 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for BDMD.
Baird Medical Investment Holdings Risk Analysis
Baird Medical Investment Holdings disclosed 83 risk factors in its most recent earnings report. Baird Medical Investment Holdings reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Baird Medical Investment Holdings Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
52 Neutral | $114.56M | -3.51 | -191.05% | ― | ― | 19.38% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
46 Neutral | $124.27M | -14.27 | -78.70% | ― | 25.59% | 55.35% | |
46 Neutral | $6.68M | -0.28 | -174.26% | ― | 41.62% | 20.47% | |
44 Neutral | $33.35M | -1.44 | -48.29% | ― | ― | ― | |
44 Neutral | $49.66M | -4.56 | -23.45% | ― | -14.27% | -132.84% |
* Healthcare Sector Average
BDMD
Baird Medical Investment Holdings
0.79
-1.63
-67.36%
APYX
Apyx Medical
2.95
0.90
43.90%
VANI
Vivani Medical
1.23
-0.24
-16.33%
XTNT
Xtant Medical Holdings
0.38
-0.25
-40.19%
ICCM
Icecure Medical
1.87
-29.63
-94.06%
Baird Medical Investment Holdings Corporate Events
Baird Medical Swings to Profit on 25% Revenue Surge in First Half of 2026
Sep 3, 2026
On September 3, 2026, Baird Medical reported preliminary unaudited financial results for the six months ended June 30, 2026, showing that revenue rose 24.6% year over year to about $9.9 million, driven largely by sales growth outside the PRC, part...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.